Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Statistical Methods for Analyzing Epidemiological Data01:25

Statistical Methods for Analyzing Epidemiological Data

Epidemiological data primarily involves information on specific populations' occurrence, distribution, and determinants of health and diseases. This data is crucial for understanding disease patterns and impacts, aiding public health decision-making and disease prevention strategies. The analysis of epidemiological data employs various statistical methods to interpret health-related data effectively. Here are some commonly used methods:
Causality in Epidemiology01:21

Causality in Epidemiology

Causality or causation is a fundamental concept in epidemiology, vital for understanding the relationships between various factors and health outcomes. Despite its importance, there's no single, universally accepted definition of causality within the discipline. Drawing from a systematic review, causality in epidemiology encompasses several definitions, including production, necessary and sufficient, sufficient-component, counterfactual, and probabilistic models. Each has its strengths and...
Distributions to Estimate Population Parameter01:26

Distributions to Estimate Population Parameter

The accurate values of population parameters such as population proportion, population mean, and population standard deviation (or variance) are usually unknown. These are fixed values that can only be estimated from the data collected from the samples. The estimates of each of these parameters are sample proportion, the sample mean, and sample standard deviation (or variance). To obtain the values of these sample statistics, data are required that have particular distribution and central...
Estimation of k and VD of Aminoglycosides01:20

Estimation of k and VD of Aminoglycosides

Aminoglycosides are a class of antibiotics used to treat various bacterial infections. Clinicians must determine the elimination rate constant (k) and volume of distribution (VD) to optimize therapeutic efficacy and minimize toxicity. The k value represents the rate at which the drug is removed from the body, and the VD reflects the degree to which the drug distributes into body tissues. Accurately estimating these parameters allows healthcare professionals to tailor drug dosing to individual...
Vaccinations01:51

Vaccinations

Overview
One-Compartment Open Model: Wagner-Nelson and Loo Riegelman Method for ka Estimation01:24

One-Compartment Open Model: Wagner-Nelson and Loo Riegelman Method for ka Estimation

This lesson introduces two critical methods in pharmacokinetics, the Wagner-Nelson and Loo-Riegelman methods, used for estimating the absorption rate constant (ka) for drugs administered via non-intravenous routes. The Wagner-Nelson method relates ka to the plasma concentration derived from the slope of a semilog percent unabsorbed time plot. However, it is limited to drugs with one-compartment kinetics and can be impacted by factors like gastrointestinal motility or enzymatic degradation.
On...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Using case description information to reduce sensitivity to bias for the attributable fraction among the exposed.

Journal of the Royal Statistical Society. Series A, (Statistics in Society)·2026
Same author

Lameness caused by intramuscular osteochondroma in semimembranosus muscle in a male cat.

JFMS open reports·2026
Same author

Catchment Influences on Carbon Stable Isotope Variation in Trout; Might It Be Methane?

Ecology and evolution·2026
Same author

Integrated Surveillance Strategies and Clinical Characteristics of Arboviral Diseases in a Pediatric Cohort in Merida, Mexico, 2021-2023.

The American journal of tropical medicine and hygiene·2026
Same author

Improving Assessment of Vaccine Effectiveness by Coupling Test-negative Design Studies with Survival Models.

Epidemiology (Cambridge, Mass.)·2026
Same author

Association between COVID-19 vaccine efficacy and epidemic force of infection.

NPJ vaccines·2026

Related Experiment Video

Updated: Jun 26, 2026

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice
08:52

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice

Published on: February 22, 2019

A Bayesian Framework for Estimating Vaccine Efficacy per Infectious Contact.

Yang Yang1, Peter Gilbert, Ira M Longini

  • 1Program of Biostatistics and Biomathematics, Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA.

The Annals of Applied Statistics
|January 27, 2009
PubMed
Summary

This study introduces a Bayesian model to accurately assess vaccine efficacy by accounting for participant contact with infectious sources and self-reporting errors. This method improves risk factor assessment in infectious disease vaccine trials.

More Related Videos

Micro-Colony Forming Unit Assay for Efficacy Evaluation of Vaccines Against Tuberculosis
06:26

Micro-Colony Forming Unit Assay for Efficacy Evaluation of Vaccines Against Tuberculosis

Published on: July 28, 2023

Experimental Human Pneumococcal Carriage
07:47

Experimental Human Pneumococcal Carriage

Published on: February 15, 2013

Related Experiment Videos

Last Updated: Jun 26, 2026

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice
08:52

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice

Published on: February 22, 2019

Micro-Colony Forming Unit Assay for Efficacy Evaluation of Vaccines Against Tuberculosis
06:26

Micro-Colony Forming Unit Assay for Efficacy Evaluation of Vaccines Against Tuberculosis

Published on: July 28, 2023

Experimental Human Pneumococcal Carriage
07:47

Experimental Human Pneumococcal Carriage

Published on: February 15, 2013

Area of Science:

  • Epidemiology
  • Biostatistics
  • Immunology

Background:

  • Contact frequency and type with infectious sources are key risk factors in infectious disease vaccine studies.
  • Standard analyses often fail to adequately adjust for these contact-related factors, potentially biasing vaccine efficacy and risk assessments.
  • Self-reported contact data can be subject to significant measurement error, complicating accurate analysis.

Purpose of the Study:

  • To develop and validate a statistical model that adjusts for measurement error in contact-related factors for improved vaccine efficacy estimation.
  • To enhance the assessment of risk factors by controlling for exposure to infection.
  • To re-analyze existing human immunodeficiency virus (HIV) vaccine trial data using the novel methodology.

Main Methods:

  • Development of a Bayesian hierarchical model.
  • Utilizing Markov chain Monte Carlo (MCMC) sampling for model fitting.
  • Application of the model to re-analyze data from two HIV vaccine studies, comparing results with standard analytical approaches.

Main Results:

  • The Bayesian model provides adjusted vaccine efficacy estimates that account for exposure and measurement error in contact data.
  • Re-analysis of HIV vaccine studies demonstrates differences compared to primary analyses using standard methods.
  • The proposed method offers a more robust approach to evaluating vaccine effectiveness in the presence of exposure variability.

Conclusions:

  • The developed Bayesian hierarchical model effectively adjusts for measurement error in contact data, leading to more accurate vaccine efficacy and risk factor assessments.
  • This methodology is applicable to various vaccine studies, including those for human immunodeficiency virus (HIV) and human papillomavirus (HPV).
  • Accurate adjustment for exposure-related factors is crucial for reliable evaluation of vaccine performance in infectious disease prevention.